These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25990559)

  • 21. Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial.
    Essex MN; Bhadra P; Sands GH
    J Int Med Res; 2012; 40(4):1357-70. PubMed ID: 22971487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients.
    Kim J; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Lee YJ; Ryu H; Lee KH; Song YW
    Clin Ther; 2009 Dec; 31(12):2860-72. PubMed ID: 20110025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
    Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
    Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
    Fleischmann RM; Flint K; Constantine G; Kolecki B
    Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee.
    Singh K; Sharma R; Rai J
    Int J Rheum Dis; 2012 Feb; 15(1):69-77. PubMed ID: 22324949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
    Kivitz AJ; Moskowitz RW; Woods E; Hubbard RC; Verburg KM; Lefkowith JB; Geis GS
    J Int Med Res; 2001; 29(6):467-79. PubMed ID: 11803730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee.
    Williams GW; Hubbard RC; Yu SS; Zhao W; Geis GS
    Clin Ther; 2001 Feb; 23(2):213-27. PubMed ID: 11293555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
    Makarowski W; Zhao WW; Bevirt T; Recker DP
    Osteoarthritis Cartilage; 2002 Apr; 10(4):290-6. PubMed ID: 11950252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study.
    Wadsworth LT; Kent JD; Holt RJ
    Curr Med Res Opin; 2016; 32(2):241-50. PubMed ID: 26506138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD; Moskowitz R
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
    Petrella RJ; Petrella M
    J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
    Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH
    Lancet; 2017 Jun; 389(10087):2375-2382. PubMed ID: 28410791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.